banner

BIOPROCESS INTERNATIONAL

  • email
  • twitter
  • linkedin
  • facebook
BPI 2026: Panel addresses cost challenges at BioProcess International event in Boston
BioProcess International kicked off its namesake and flagship event yesterday in Boston, Massachusetts, with a series of educational talks and...

Decentralized Apheresis: The Missing Link in Equitable Cell and Gene Therapy Access?
Cell and gene therapies (CGTs) promise to transform medicine, offering potential cures for diseases that were previously untreatable. Although...

Making more than chocolate: Swiss CDMO gets go-ahead to make siRNAs
Earlier this month, Swiss-based contract development and manufacturing organization (CDMO) ten23 health announced GMP certification to...

FDA committee approves loosening peptide regulation despite own evidence
Last week, the US Food and Drug Administration (FDA) held a two-day advisory committee meeting concerning popular “gray market” peptides. The...

More From BioProcess Insider
Pfizer will produce its COVID-19 vaccine from its Grange Castle facility in Dublin, as part of a $40 million investment. The firm’s partnership...

Thermo teams with UCSF on San Fran cell therapy center
Thermo Fisher Scientific has teamed up with the University of California, San Francisco (UCSF) to set up a cell therapy manufacturing...

Pfizer invests $40m to manufacture COVID-19 vaccine in Ireland
Pfizer will produce its COVID-19 vaccine from its Grange Castle facility in Dublin, as part of a $40 million investment. The firm’s partnership...

Canada pays $164 million to add Resilience to pandemic prep effort
Canada has called on Resilience Biotechnologies to boost local COVID-19 shot capacity. The Canadian Government has given contract development...

Chime’s in: Humanigen adds Chinese CDMO to support COVID mAb
Humanigen has contracted Chime Biologics to supply its potential COVID-19 therapy lenzilumab outside of the US. Lenzilumab is in late-stage...